Logo image of CXI.CA

CURRENCY EXCHANGE INTERNATIO (CXI.CA) Stock Fundamental Analysis

TSX:CXI - Toronto Stock Exchange - US23131B3078 - Common Stock - Currency: CAD

21  0 (0%)

Fundamental Rating

5

Overall CXI gets a fundamental rating of 5 out of 10. We evaluated CXI against 7 industry peers in the Consumer Finance industry. No worries on liquidiy or solvency for CXI as it has an excellent financial health rating, but there are worries on the profitability. CXI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CXI was profitable.
In the past year CXI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CXI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CXI reported negative operating cash flow in multiple years.
CXI.CA Yearly Net Income VS EBIT VS OCF VS FCFCXI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

With a Return On Assets value of 1.98%, CXI perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.07%, CXI is in line with its industry, outperforming 57.14% of the companies in the same industry.
CXI has a better Return On Invested Capital (7.58%) than 71.43% of its industry peers.
CXI had an Average Return On Invested Capital over the past 3 years of 8.03%. This is below the industry average of 10.75%.
Industry RankSector Rank
ROA 1.98%
ROE 3.07%
ROIC 7.58%
ROA(3y)6.33%
ROA(5y)1.59%
ROE(3y)10.99%
ROE(5y)3.28%
ROIC(3y)8.03%
ROIC(5y)N/A
CXI.CA Yearly ROA, ROE, ROICCXI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CXI has a Profit Margin of 2.80%. This is comparable to the rest of the industry: CXI outperforms 57.14% of its industry peers.
In the last couple of years the Profit Margin of CXI has declined.
CXI's Operating Margin of 16.25% is fine compared to the rest of the industry. CXI outperforms 71.43% of its industry peers.
In the last couple of years the Operating Margin of CXI has grown nicely.
Industry RankSector Rank
OM 16.25%
PM (TTM) 2.8%
GM N/A
OM growth 3YN/A
OM growth 5Y5.24%
PM growth 3YN/A
PM growth 5Y-16.12%
GM growth 3YN/A
GM growth 5YN/A
CXI.CA Yearly Profit, Operating, Gross MarginsCXI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

7

2. Health

2.1 Basic Checks

CXI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CXI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CXI has less shares outstanding
Compared to 1 year ago, CXI has an improved debt to assets ratio.
CXI.CA Yearly Shares OutstandingCXI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CXI.CA Yearly Total Debt VS Total AssetsCXI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.69 indicates that CXI is not in any danger for bankruptcy at the moment.
CXI has a better Altman-Z score (3.69) than 100.00% of its industry peers.
CXI has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CXI (0.14) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACC0.95
WACC8%
CXI.CA Yearly LT Debt VS Equity VS FCFCXI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.03 indicates that CXI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.03, CXI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CXI has a Quick Ratio of 3.03. This indicates that CXI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.03, CXI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 3.03
CXI.CA Yearly Current Assets VS Current LiabilitesCXI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

CXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.00%.
CXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.90% yearly.
Looking at the last year, CXI shows a small growth in Revenue. The Revenue has grown by 3.93% in the last year.
Measured over the past years, CXI shows a quite strong growth in Revenue. The Revenue has been growing by 15.33% on average per year.
EPS 1Y (TTM)-10%
EPS 3YN/A
EPS 5Y-3.9%
EPS Q2Q%30.77%
Revenue 1Y (TTM)3.93%
Revenue growth 3Y40.76%
Revenue growth 5Y15.33%
Sales Q2Q%9.86%

3.2 Future

CXI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.26% yearly.
CXI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y65.57%
EPS Next 2Y35.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.66%
Revenue Next 2Y3.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CXI.CA Yearly Revenue VS EstimatesCXI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
CXI.CA Yearly EPS VS EstimatesCXI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.21 indicates a correct valuation of CXI.
CXI's Price/Earnings ratio is a bit cheaper when compared to the industry. CXI is cheaper than 71.43% of the companies in the same industry.
CXI is valuated cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.87 indicates a rather cheap valuation of CXI.
Based on the Price/Forward Earnings ratio, CXI is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
CXI is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.21
Fwd PE 6.87
CXI.CA Price Earnings VS Forward Price EarningsCXI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXI is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.6
CXI.CA Per share dataCXI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CXI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CXI's earnings are expected to grow with 35.26% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y35.26%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXI!.
Industry RankSector Rank
Dividend Yield N/A

CURRENCY EXCHANGE INTERNATIO

TSX:CXI (6/6/2025, 7:00:00 PM)

21

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)06-10 2025-06-10
Inst Owners8.21%
Inst Owner ChangeN/A
Ins Owners25.95%
Ins Owner ChangeN/A
Market Cap131.67M
Analysts80
Price Target30.6 (45.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.84%
Min EPS beat(2)-37.66%
Max EPS beat(2)-36.02%
EPS beat(4)0
Avg EPS beat(4)-39.55%
Min EPS beat(4)-71.71%
Max EPS beat(4)-12.81%
EPS beat(8)1
Avg EPS beat(8)-30.45%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.67%
Min Revenue beat(2)-5.7%
Max Revenue beat(2)7.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-5.7%
Max Revenue beat(4)7.03%
Revenue beat(8)4
Avg Revenue beat(8)1.16%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.21
Fwd PE 6.87
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 1.27
EV/EBITDA 0.6
EPS(TTM)1.72
EY8.19%
EPS(NY)3.05
Fwd EY14.55%
FCF(TTM)-1.73
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS19
BVpS17.34
TBVpS16.58
PEG (NY)0.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.98%
ROE 3.07%
ROCE 16.29%
ROIC 7.58%
ROICexc N/A
ROICexgc N/A
OM 16.25%
PM (TTM) 2.8%
GM N/A
FCFM N/A
ROA(3y)6.33%
ROA(5y)1.59%
ROE(3y)10.99%
ROE(5y)3.28%
ROIC(3y)8.03%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.98%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y5.24%
PM growth 3YN/A
PM growth 5Y-16.12%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.62
Cap/Depr 83.38%
Cap/Sales 3.61%
Interest Coverage 303.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.03
Quick Ratio 3.03
Altman-Z 3.69
F-Score4
WACC8%
ROIC/WACC0.95
Cap/Depr(3y)48.53%
Cap/Depr(5y)34.74%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10%
EPS 3YN/A
EPS 5Y-3.9%
EPS Q2Q%30.77%
EPS Next Y65.57%
EPS Next 2Y35.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.93%
Revenue growth 3Y40.76%
Revenue growth 5Y15.33%
Sales Q2Q%9.86%
Revenue Next Year2.66%
Revenue Next 2Y3.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.85%
EBIT growth 3YN/A
EBIT growth 5Y21.37%
EBIT Next Year34.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.07%
FCF growth 3Y45.9%
FCF growth 5Y20.75%
OCF growth 1Y35.72%
OCF growth 3Y49.32%
OCF growth 5Y19.49%